{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T04:11:21Z","timestamp":1750219881965,"version":"3.41.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Research in Social and Administrative Pharmacy"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.sapharm.2025.05.003","type":"journal-article","created":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T12:07:45Z","timestamp":1746792465000},"page":"722-728","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of PROMPT questionnaire-based pharmaceutical care on pharmaceutical therapy and health-related quality of life in non-dialysis chronic kidney disease patients: A randomized controlled trial"],"prefix":"10.1016","volume":"21","author":[{"given":"Paphawee","family":"Wanpen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phantipa","family":"Sakthong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.sapharm.2025.05.003_bib1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","year":"2013","journal-title":"Kidney Int Suppl"},{"issue":"5","key":"10.1016\/j.sapharm.2025.05.003_bib2","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1093\/ndt\/gfp669","article-title":"Prevalence and risk factors of chronic kidney disease in the Thai adult population: Thai SEEK study","volume":"25","author":"Ingsathit","year":"2010","journal-title":"Nephrol Dial Transplant"},{"year":"2022","series-title":"Clinical Practice Recommendations for Evaluation and Management of Chronic Kidney Disease in Adults 2022","key":"10.1016\/j.sapharm.2025.05.003_bib3"},{"issue":"2","key":"10.1016\/j.sapharm.2025.05.003_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0212184","article-title":"Quality of life and its predictors among patients with chronic kidney disease: a hospital-based cross sectional study","volume":"14","author":"Kefale","year":"2019","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.sapharm.2025.05.003_bib5","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1053\/j.ajkd.2013.07.004","article-title":"Patient-reported outcomes in clinical trials of CKD-related therapies: report of a symposium sponsored by the national kidney foundation and the U.S. Food and Drug Administration","volume":"62","author":"Perrone","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"10.1016\/j.sapharm.2025.05.003_bib6","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1007\/s11096-019-00816-4","article-title":"Clinical pharmacy practice in the care of chronic kidney disease patients: a systematic review","volume":"41","author":"Al Raiisi","year":"2019","journal-title":"Int J Clin Pharm"},{"issue":"1","key":"10.1016\/j.sapharm.2025.05.003_bib7","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/ndt\/gfr287","article-title":"Pharmacists' interventions in the management of patients with chronic kidney disease: a systematic review","volume":"27","author":"Salgado","year":"2012","journal-title":"Nephrol Dial Transplant"},{"year":"2011","series-title":"Effect of Pharmaceutical Care on the Control of Risk Factors for Progression of Renal Function in Patients with Chronic Kidney Disease at Thasala Hospital","author":"Nuanchuay","key":"10.1016\/j.sapharm.2025.05.003_bib9"},{"key":"10.1016\/j.sapharm.2025.05.003_bib8","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s12882-015-0052-2","article-title":"A pharmacist based intervention to improve the care of patients with CKD: a pragmatic, randomized, controlled trial","volume":"16","author":"Cooney","year":"2015","journal-title":"BMC Nephrol"},{"issue":"1","key":"10.1016\/j.sapharm.2025.05.003_bib10","first-page":"14","article-title":"Effects of Exercise program during hemodialysis on fatigue and quality of life in ends state renal disease patients","volume":"6","author":"Tummanittayangkoon","year":"2013","journal-title":"Siriraj Nursing Journal"},{"issue":"1","key":"10.1016\/j.sapharm.2025.05.003_bib11","first-page":"79","article-title":"Quality of life in end stage renal disease patients undergoing hemodialysis according to the different health benefit schemes: case study at a private hospital","volume":"18","author":"Yisoonkaew","year":"2016","journal-title":"Vajira nursing journal"},{"issue":"2","key":"10.1016\/j.sapharm.2025.05.003_bib12","first-page":"172","article-title":"Quality of life assessment among patients on hemodialysis and peritoneal dialysis at Phayao Hospital","volume":"7","author":"Laolam","year":"2014","journal-title":"Naresaun Phayao J"},{"issue":"2","key":"10.1016\/j.sapharm.2025.05.003_bib13","first-page":"40","article-title":"Quality of life and effecting factors in patients undergoing dialysis: a comparative study","volume":"6","author":"Chinnoros","year":"2020","journal-title":"J Health & Health Manag."},{"key":"10.1016\/j.sapharm.2025.05.003_bib14","first-page":"2","article-title":"Pharmaceutical therapy-related quality of life: conceptual development","volume":"18","author":"Murawski","year":"2001","journal-title":"J Soc Adm Pharm"},{"key":"10.1016\/j.sapharm.2025.05.003_bib15","doi-asserted-by":"crossref","DOI":"10.1007\/s11096-014-9970-5","article-title":"Measuring the impact of long-term medicines use from the patient perspective","volume":"36","author":"Krska","year":"2014","journal-title":"Int J Clin Pharm"},{"issue":"3","key":"10.1016\/j.sapharm.2025.05.003_bib16","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.sapharm.2014.10.002","article-title":"Development of patient-reported outcomes measure of pharmaceutical therapy for quality of life (PROMPT-QoL): a novel instrument for medication management","volume":"11","author":"Sakthong","year":"2015","journal-title":"Res Social Adm Pharm"},{"issue":"3","key":"10.1016\/j.sapharm.2025.05.003_bib17","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/s11096-018-0638-4","article-title":"Development and psychometrics of a short-form pharmaceutical care-specific measure for quality of life","volume":"40","author":"Sakthong","year":"2018","journal-title":"Int J Clin Pharm"},{"issue":"4","key":"10.1016\/j.sapharm.2025.05.003_bib18","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.sapharm.2017.05.001","article-title":"A randomized controlled trial of the impact of pharmacist-led patient-centered pharmaceutical care on patients' medicine therapy-related quality of life","volume":"14","author":"Sakthong","year":"2018","journal-title":"Res Social Adm Pharm"},{"year":"2019","series-title":"Outcome of Pharmacist-Led Pharmaceutical Care in the Elderly Hospitalized Patients","author":"Chartwiwatpornchai","key":"10.1016\/j.sapharm.2025.05.003_bib19"},{"issue":"3","key":"10.1016\/j.sapharm.2025.05.003_bib20","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/jppr.1909","article-title":"Effectiveness of pharmaceutical care for improving medication-related quality of life and adherence to treatment among people living with schizophrenia: a randomised controlled trial","volume":"54","author":"Sriboonruang","year":"2024","journal-title":"J Pharm Pract Res"},{"issue":"2","key":"10.1016\/j.sapharm.2025.05.003_bib21","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s11096-023-01692-9","article-title":"Comparison of the sensitivities of pharmacotherapy-related and disease-specific quality of life measures in response to pharmacist-led pharmaceutical care for cancer outpatients: a randomised controlled trial","volume":"46","author":"Sakthong","year":"2024","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/j.sapharm.2025.05.003_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.sapharm.2024.08.003","article-title":"Impact of pharmacist-led pharmaceutical care on health-related and pharmaceutical therapy-related quality of life in patients with heart failure: a randomized controlled trial","author":"Sakthong","year":"2024","journal-title":"Res Social Adm Pharm"},{"issue":"4","key":"10.1016\/j.sapharm.2025.05.003_bib23","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3758\/BRM.41.4.1149","article-title":"Statistical power analyses using G\u2217Power 3.1: tests for correlation and regression analyses","volume":"41","author":"Faul","year":"2009","journal-title":"Behav Res Methods"},{"issue":"1","key":"10.1016\/j.sapharm.2025.05.003_bib24","first-page":"496","article-title":"Sample size calculation using G\u2217power program","volume":"5","author":"Sanitlou","year":"2019","journal-title":"SVIT journal"},{"year":"1997","series-title":"Kidney Disease Quality of Life Short Form (KDQOL-SF \u2122), Version 1.3: A Manual for Use and Scoring","author":"Hays","key":"10.1016\/j.sapharm.2025.05.003_bib25"},{"year":"2009","series-title":"Reliability and Validity of the Thai Version of the Kidney Disease Quality of Life-Short Form [superscript TM] Questionnaire [Internet]","author":"Homjean","key":"10.1016\/j.sapharm.2025.05.003_bib26"}],"container-title":["Research in Social and Administrative Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741125002426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1551741125002426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T17:03:59Z","timestamp":1750179839000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1551741125002426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":26,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S1551741125002426"],"URL":"https:\/\/doi.org\/10.1016\/j.sapharm.2025.05.003","relation":{},"ISSN":["1551-7411"],"issn-type":[{"type":"print","value":"1551-7411"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of PROMPT questionnaire-based pharmaceutical care on pharmaceutical therapy and health-related quality of life in non-dialysis chronic kidney disease patients: A randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"Research in Social and Administrative Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.sapharm.2025.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}